Adamed Pharma is a Polish pharmaceutical and biotechnology company that emerged from its own scientific research and patented innovations. Currently, it is a manufacturer of approximately 500 products available to patients in 78 countries worldwide. The company has representative offices in Spain, Russia, the Czech Republic, Vietnam, Italy, Kazakhstan, Uzbekistan, as well as Slovakia and Ukraine. Employing around 2,400 people, Adamed has been engaged in its own innovative research and development activities for over 20 years. It collaborates with leading universities and research institutes both domestically and internationally. The company's intellectual property is protected by more than 200 patents across most countries in the world. Adamed also holds a controlling stake in Dat Vi Phu, one of the fastest-growing local pharmaceutical firms in Vietnam. This transaction marked the largest direct Polish investment in Vietnam to date. In 2019, Adamed acquired a stake in the Italian company Ecupharma, which operates in the fields of neuropsychiatry and urology.

Services include:
- Finished Dosage Formulation
- Research and Development
- Manufacturing
- Regulatory Affairs
- Quality Control
- Supply Chain Management

Adamed Pharma continues to thrive as a significant player in the pharmaceutical industry, advancing healthcare through its innovative products and services. For more information, please visit adamed.com.